SEC 13F Intelligence

Sr One Capital Management, LP / SPRY

Sr One Capital Management, LP’s Ars Pharmaceuticals Inc Position

Does Sr One Capital Management, LP own Ars Pharmaceuticals Inc (SPRY)? Yes — 4.01M shares worth $32M (+3.52% of its 13F portfolio) as of Q1 2026.

Position Value
$32M
Q1 2026
Shares
4.01M
% of Portfolio
+3.52%
Quarters Held
14
currently held

Position History SPRY

Reported value by quarter
Q4 ’22: $26MQ4 ’22Q1 ’23: $26MQ2 ’23: $27MQ2 ’23Q3 ’23: $15MQ4 ’23: $22MQ4 ’23Q1 ’24: $41MQ2 ’24: $34MQ2 ’24Q3 ’24: $58MQ4 ’24: $42MQ4 ’24Q1 ’25: $50MQ2 ’25: $70MQ2 ’25Q3 ’25: $40MQ4 ’25: $47MQ4 ’25Q1 ’26: $32Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20264.01M$32M+3.52%
Q4 20254.01M$47M+6.62%
Q3 20254.01M$40M+5.83%
Q2 20254.01M$70M+15.18%
Q1 20254.01M$50M+12.97%
Q4 20244.01M$42M+10.32%
Q3 20244.01M$58M+11.67%
Q2 20244.01M$34M+10.69%
Q1 20244.01M$41M+11.26%
Q4 20234.01M$22M+9.23%
Q3 20234.01M$15M+7.77%
Q2 20234.01M$27M+11.59%
Q1 20234.01M$26M+9.73%
Q4 20223.01M$26M+9.37%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sr One Capital Management, LP’s full portfolio or all institutional holders of SPRY.